Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11912778 Methods of engineering transferrin receptor binding polypeptides

Patent 11912778 was granted and assigned to Denali Therapeutics on February, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 2 Mar, 2024
"Created via: Patent importer"
Golden AI profile picture
Golden AI
created this topic on 2 Mar, 2024
Edits made to:
Infobox (+63 properties)
Article (+230 characters)
‌

 US Patent 11912778 Methods of engineering transferrin receptor binding polypeptides

Article

Patent abstract

Provided herein are polypeptides that bind to a transferrin receptor, methods of generating such polypeptides, and methods of using the polypeptides to target a composition to a transferrin receptor-expressing cell.

Infobox
Is a
Patent
Patent
0
Patent Applicant
Denali Therapeutics
Denali Therapeutics
0
Current Assignee
Denali Therapeutics
Denali Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
119127780
Patent Inventor Names
Adam P. Silverman0
Ankita Srivastava0
Joy Yu Zuchero0
Mark S. Dennis0
Mihalis Kariolis0
Robert C. Wells0
Ryan J. Watts0
Xiaocheng Chen0
Date of Patent
February 27, 2024
0
Patent Application Number
178884060
Date Filed
August 15, 2022
0
Patent Citations
‌
US Patent 11124567 Anti-TREM2 antibodies and methods of use thereof
0
‌
US Patent 7241449 Transferrin receptor genes of
0
‌
US Patent 7371826 Polypeptide variants with altered effector function
0
‌
US Patent 7670600 Molecules with extended half-lives, compositions and uses thereof
0
‌
US Patent 7741446 Fusion antibodies that cross the blood-brain barrier in both directions
0
‌
US Patent 7744879 Blood-brain barrier targeting antibodies
0
‌
US Patent 8053567 Modified surface material, method for preparing same and uses thereof
0
‌
US Patent 8084254 Human blood brain barrier model
0
‌
US Patent 8088376 Fc variants with altered binding to FcRn
0
‌
US Patent 8293495 Blood-brain barrier model
0
‌
US Patent 8313924 Muteins of tear lipocalin and methods for obtaining the same
0
‌
US Patent 8394925 Fc variants with altered binding to FcRn
0
‌
US Patent 8417465 Synthetic microfluidic blood-brain barrier
0
‌
US Patent 8475792 Molecules with extended half-lives, compositions and uses thereof
0
‌
US Patent 8497246 Methods for diagnosing and treating CNS disorders by trans-blood-brain barrier delivery of protein compositions
0
‌
US Patent 8609065 Molecules for targeting compounds to various selected organs, tissues or tumor cells
0
‌
US Patent 8753610 Methods for diagnosing CNS disorders with fusion antibodies that cross the blood-brain barrier in both directions
0
‌
US Patent 8759297 Genetically encoded multifunctional compositions bidirectionally transported between peripheral blood and the cns
0
‌
US Patent 8859738 Cytotoxic immunoglobulin
0
‌
US Patent 8900865 Blood brain barrier device
0
‌
US Patent 8921279 Display of binding agents
0
‌
US Patent 9005973 Targeted genomic modification with partially single-stranded donor molecules
0
‌
US Patent 9133274 Method for engineering immunoglobulins
0
‌
US Patent 9156889 Drug transporter permeating blood-brain barrier, peptide and use thereof
0
‌
US Patent 9513280 Microfluidic biological barrier model and associated method
0
‌
US Patent 9611323 Low affinity blood brain barrier receptor antibodies and uses therefor
0
‌
US Patent 9708406 Anti-transferrin receptor antibodies and methods of use
0
‌
US Patent 9803023 Fc variants with altered binding to FcRn
0
‌
US Patent 9856311 Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions
0
‌
US Patent 9890209 Anti-alpha-synuclein antibodies and methods of use
0
‌
US Patent 9993564 Blood brain barrier shuttle
0
‌
US Patent 9994641 Anti-human transferrin receptor antibody that passes through blood-brain barrier
0
‌
US Patent 10143187 Transferrin receptor transgenic models
0
‌
US Patent 10144783 Macromolecular compositions that cross the blood-brain barrier and methods of use thereof
0
‌
US Patent 10233252 pH-dependent antibodies targeting the transferrin receptor and methods of use thereof to deliver a therapeutic agent
0
‌
US Patent 10251952 Humanized anti-tau(pS422) antibody brain shuttles and use thereof
0
‌
US Patent 10323089 Anti-transferrin receptor antibodies with tailored affinity
0
‌
US Patent 10364292 Monovalent blood brain barrier shuttle modules
0
‌
US Patent 10385118 Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions
0
‌
US Patent 10457717 Engineered polypeptides
0
‌
US Patent 10508151 Anti-transferrin receptor antibodies and methods of use
0
‌
US Patent 10759864 Anti-human transferrin receptor antibody capable of penetrating blood-brain barrier
0
‌
US Patent 10808036 Anti-transferrin receptor antibodies and methods of use
0
‌
US Patent 10870837 Fusion proteins comprising enzyme replacement therapy enzymes
0
‌
US Patent 11008403 Anti-transferrin receptor / anti-BACE1 multispecific antibodies and methods of use
0
‌
US Patent 11643446 Progranulin variants
0
Patent Primary Examiner
‌
Christian C Boesen
0

Find more entities like US Patent 11912778 Methods of engineering transferrin receptor binding polypeptides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo